Merck KGaA leadership
Executive Summary
Merck KGaA appoints Michael Roemer chairman effective immediately, company announced Nov. 22. Roemer has worked at Merck KGaA for 27 years, and was named vice chairman in 2000. He succeeds Bernhard Scheuble who announced his resignation after 24 years with the company. In addition to serving as chairman, Scheuble also oversaw the pharmaceutical business unit, which will now be run by Elmar Schnee, the company says...